OGT expression was significantly upregulated in colorectal cancer (CRC), stomach adenocarcinoma (STAD), lung adenocarcinoma (LUAD), liver hepatocellular carcinoma (LIHC) and prostate adenocarcinoma (PRED) tissues compared to the adjacent normal tissues (Fig. S1A). Here, OGT is linked to prostate adenocarcinoma.